Close Menu

NEW YORK – HTG Molecular Diagnostics said in a regulatory document on Thursday that it may offer up to $20 million in shares of its common stock from time to time.

It also signed a sales agreement with Cantor Fitzgerald for the possible sale of the shares, the Tucson, Arizona-based molecular profiling firm said in a document filed with the US Securities and Exchange Commission. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.